What is the ARAD study?
Type 1 diabetes is a lifelong and serious condition. It occurs when the immune system makes a mistake and destroys the beta cells in the pancreas which make insulin.
Markers found in blood called islet autoantibodies indicate that beta cell destruction process has begun. This process can begin many years sometimes decades before symptoms appear.
Diagnosis of type 1 diabetes usually occur when approximately 80% of beta cells have been destroyed.
- The ARAD study is open to both adults and children previously identified (by taking part in other research studies) as having ‘one or multiple islet autoantibody risk markers’ for developing type 1 diabetes in the future.
- People who take part will be followed up to Identify which genetic, biological and environmental factors can be linked with symptoms developing quickly or slowly.
- Participants will be offered access to information about the symptoms of type 1 diabetes, its management, and clinical trials aimed at prevention of the condition